Oxford-based pharmatech company uses artificial intelligence to find drug against COVID-19
Scientists at Oxford-based pharmatech company Exscientia are hoping to find a drug against COVID-19 within a year, using artificial intelligence technology.
In mid-March, they received a set of 12,000 de-risked drugs (drug molecules and molecules that have been checked for human safety) from the Calibr Institute based in California.
The lab has selected four different viral targets, which are proteins from the SARS-CoV-2 and are checking if they are affecting the molecules.
Scientific coordinator Aude Echalier says that it is essential to consider the "small molecule drug route" as a vaccine may never be found.
(Source: AFP)
Children risk 'generational catastrophe' from COVID: Watchdog
WHO in ‘imminent danger’ due to funding shortage: Top expert
‘New strain of coronavirus may have leaked from UK vaccine lab’
The important of Venezuela for Iran
Iran beats traditional rival Russia in freestyle and Greco-Roman wrestling friendly
Rape trials trigger protests against French ‘sexist and misogynistic’ culture
US photographer opens Berlin exhibition with anti-Israel speech
VIDEO | Press TV's News Headlines
VIDEO | US 'non-profit killer’ bill targets pro-Palestinian groups
Explainer: How Yemeni military chased away US aircraft carrier from Red Sea?
French march for women of Palestine
PressTV NEWSLETTER
now
This makes it easy to access the Press TV website
